Personalis (PSNL) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

PSNL Personalis

Watchlist

3.390
-0.070-2.02%

Trading Nov 21 09:57 ET

239.50MMarket Cap-1959P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Personalis to Participate at Upcoming Investor Conferences
Businesswire16:01 ET
Morgan Stanley Maintains Personalis(PSNL.US) With Hold Rating, Maintains Target Price $5
Moomoo NewsNov 19 09:31 ET · Ratings
Morgan Stanley Maintains Personalis(PSNL.US) With Hold Rating, Raises Target Price to $5
Moomoo NewsNov 19 03:36 ET · Ratings
Personalis: Promising Growth in Biopharma Sales Amidst Strategic Challenges – Hold Rating Maintained
TipRanksNov 18 20:48 ET · Ratings
Cathie Wood's ARK Investment Bought 266.8K Shares of Personalis Today
TipRanksNov 14 20:05 ET
Here's Why We're Not Too Worried About Personalis' (NASDAQ:PSNL) Cash Burn Situation
Yahoo FinanceNov 9 09:25 ET

Comments

Happy_SG

Nov 15 18:39

$Personalis (PSNL.US)$ hmmm.... anyone knows what happened? the results wasn't that bad to warrant such a fail.

Stock_Drift

Aug 18 17:37

8/19/24 🦍’s 👀’s on 🚨🚨🚨🚨

$Virax Biolabs (VRAX.US)$ $Airship AI (AISP.US)$ $Personalis (PSNL.US)$ $Emergent BioSolutions (EBS.US)$ $Chimerix (CMRX.US)$ $Tonix Pharmaceuticals (TNXP.US)$
📊⚡️📊

Stock Region

Aug 18 17:13

Medical Company Announces Expanded Collaboration With Technology Firm

Expanding Horizons in Cancer Management: The Collaboration of Personalis, Inc. and Tempus AI, Inc..
In a world where technological advancements continually reshape the landscape of healthcare, collaboration among industry leaders plays a pivotal role in accelerating innovation. A testament to this is the expanded collaboration between Personalis, Inc., a renowned leader in cancer genomics, and Tempus AI, Inc., a technology-driv...